Abstract
The plasma levels of free estradiol are very low in postmenopausal women. However, concentrations of estrogens within breast tissue have been reported to be higher than in plasma and similar to plasma concentrations in premenopausal women. One mechanism by which this may occur is for breast cells to synthesize estrogens themselves and produce high concentrations locally. Thus, tumor aromatase may be a significant source of estrogen which stimulates tumor growth. To address the question of the importance of this pathway, we have investigated the expression of aromatase within the normal breast and breast cancers. Because conventional biochemical assays for measuring aromatase activity require relatively large amounts of tissue, we developed an immunocytochemical method using a monoclonal antibody to determine the expression of aromatase. The method can be applied to sections of tumors embedded in paraffin blocks as routinely prepared for pathology. Since we have previously shown that mRNA for aromatase (P450 arom) and the protein are expressed in the same cells of the human placenta, we used in situ hybridization of sequence specific probes to P450 arom mRNA in breast tissue as one method to verify the specificity of the immunocytochemical detection of the enzyme. Both immunocytochemistry and in situ hybridization identified aromatase enzyme and mRNA expression in the epithelial cells of the terminal ductal lobula units (TDLU) and surrounding stromal cells of the normal human breast, and in the tumor epithelial cells and stromal cells of breast cancers. In addition, evidence for the functional significance of tumor aromatase was indicated by a correlation between aromatase activity and expression of proliferating cell nuclear antigen (PCNA) in the tumor, and by increased thymidine incorporation into DNA in response to testosterone in tumors in histoculture which had high aromatase activity but not in those with low activity. The findings suggests that estrogen produced locally is important in enhancing proliferation of the tumor.
Similar content being viewed by others
References
Hemsell DL, Gordon J, Breuner PF, Siiteri PK: Plasma precursors of estrogen. II Correlation of the extend of conversion of plasma androstenedione to estrone with age. J Clin Endocrinol Metab 38: 476–479, 1974
Longcope C, Pratt JH, Schneider SH, Fineberg SE: In vivo studies on the metabolism of estrogens by muscle and adipose tissue of normal males. J Clin Endocrinol Metab 43: 1134–1145, 1976
Thorsen T, Tangen M, Stoa KF: Concentrations of endogenous estradiol as related to estradiol receptor sites in breast tumor cytosol. Eur J Cancer Clin Oncol 18: 333–337, 1982
van Landeghem AAJ, Portman J, Nabauurs M: Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue. Cancer Res 45: 2900–2906, 1985
Masamura S, Santner SJ, Gimtly P, George J, Santen RJ: Mechanism for maintenance of high breast tumor estradiol concentrations in the absence of ovarian function: Role of very high affinity tissue uptake. Breast Cancer Res Treat 42: 215–226, 1997
Reed MJ, Purohit A: Sulphatase inhibitors: the rationale for the development of a new endocrine therapy. Rev Endocr Rel Cancer 45: 51–62, 1993
Miller WR, Forrest APM: Estradiol synthesis from C19 steroids by human breast cancer. Br J Cancer 33: 16–18, 1974
Lipton A, Santen RJ, Santen SJ, Harvey HA, Peil PD, White-Hershey D, Bartholomew MJ, Antle CE: Aromatase activity in primary and metastatic human breast cancer. Cancer 59: 779–783, 1987
Li K, Adams JB: Aromatization of testosterone and oestrogen receptor levels in human breast cancer. J Steroid Biochem Mol Biol 14: 269–272, 1981
Lu Q, Nakamura J, Savinov A, Yue W, Weisz J, Dabbs DJ, Wolz G, Brodie A: Expression of aromatase protein and messenger ribonucleic acid in tumor epithelial cells and evidence of functional significance of locally produced estrogen in human breast cancers. Endocrinol 137: 3061–3068, 1996
Corbin C, Graham-Lorence S, McPhaul M, Mason J, Mendelson C, Simpson E: Isolation of a full-length cDNA insert encoding human aromatase system cytochrome p450 and its expression in nonsteroidogenic cells. Proc Natl Acad Sci USA 85: 8945–8952, 1988
Inkster SE, Brodie AMH: Expression of aromatase cytochrome P450 in premenopausal and postmenopausal human ovaries: and immunocytochemical study. J Clin Endocrinol Metab 73: 717–726, 1991
Brodie AMH, Schwarzel WC, Shaikh AA, Brodie HJ: The effect of an aromatase inhibitor, 4-hydroxy-4-androstene-3, 17-dione, on estrogen dependent processes in reproduction and breast cancer. Endocrinol 100: 1684–1694, 1977
Banks P, Brodie AMH, Petersen S, Zoeller T, Barraclough C: Localization of aromatase mRNA in human term placenta by in sity hybridization histochemistry. The 71th Ann Meeting of Endocrine Society, Seattle, WA., 1989, (Abstract)
Long BJ, Lu Q, Rodriguez-Valenzuela C, Brodie AM: Aromatase expression in cells isolated from the normal breast. 79th Ann Meeting of Endocrine Society, Minneapolis, MN., 1997
Inkster SE, Brodie AMH: Human testicular aromatase: immunocytochemical and biochemical studies. J Clin Endocrinol Metab 80: 1941–1947, 1995
Inkster SE, Brodie AMH: Immunocytochemical studies of aromatase in early and full term human placental tissues: comparison with biochemical assays. Biol Reprod., 41, 889–898, 1989
Esteban JM, Warsi Z, Haniu M, Hall P, Shively JE, Chen S: Detection of intratumoral aromatase in breast carcinomas. Am J Pathol 140: 337–343.20, 1992.
Hall PA, Levison DA, Woods AL, Yu CCW, Kellock DB, Wathins JA, Barnes DM, Gillett CE, Camplejohn R, Dover R, Waseem NH, Lane DP: Proliferating cell nuclear antigen immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 162: 285–294, 1990
Narita T, Funahashi H, Satoh Y, Takagi H: Proliferating cell nuclear antigen immunostaining in breast cancer and its relation to prognosis. Jpn J Clin Oncol 23: 20–25, 1993
Li K, Adams JB: Aromatization of testosterone and oestrogen receptor levels in human breast cancer. J Steroid Biochem Mol Biol 14: 269–272, 1981
Marigilka CS, Martin GR, Mitch D, Barry G, McKinna JA, Ian F, Coombes RC: Intratumoral aromatase as a prognostic factor in human breast carcinoma. Cancer Res 49: 2588–2591, 1989
Miller WR, Anderson TJ, Jack WLJ: Relationship between tumor aromatase activity, tumor characteristics and response to therapy. J Steroid Biochem Molec Biol 37: 1055–1059, 1990
Reed MJ, Lai LC, Owen AM, Singh A, Coldham NG, Purohit A, Ghilchik MW, Shaikh NA, James VHT: Effect of treatment with 4-hydroxyandrostenedione on the peripheral conversion of androstenedione to estrone and in vivo tumor aromatase activity in postmenopausal women with breast cancer. Cancer Res 50: 193–196, 1990
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Brodie, A., Long, B. & Lu, Q. Aromatase expression in the human breast. Breast Cancer Res Treat 49 (Suppl 1), S85–S91 (1998). https://doi.org/10.1023/A:1006029612990
Issue Date:
DOI: https://doi.org/10.1023/A:1006029612990